Becton Dickinson announced that Ronald Silverman has been named executive vice president and chief medical officer of BD, effective December 4. Silverman will be responsible for leading the company’s Medical Affairs organization, which includes end-to-end medical affairs across BD’s business units, regions and central team. Silverman will report to Beth McCombs, executive vice president and chief technology officer for BD, and serve as a member of the BD executive leadership team.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on BDX:
- Becton Dickinson earnings selloff a buying opportunity, says Barclays
- Becton Dickinson price target lowered to $280 from $305 at Piper Sandler
- Becton Dickinson sees FY24 adjusted EPS $12.70-$13.00, consensus $13.49
- Becton Dickinson reports Q4 adjusted EPS $3.42, consensus $3.42
- Correction: Becton Dickinson reports Q4 adjusted EPS $3.42, consensus $3.42